相关实验视频
Updated: Sep 12, 2025

09:32
Differentiation of Mouse Breast Epithelial HC11 and EpH4 Cells
Published on: February 27, 2020
9.1K
暂时的CB2受体激活触发了乳腺癌中通过染色质重塑的不可逆转的光分化
bioRxiv : the preprint server for biology
|August 6, 2025
概括
乳腺癌细胞中的大麻素受体2 (CB2R) 激活会触发稳定的分化途径,减少瘤生长并增加治疗灵敏度. 这种表观遗传重编程为抗癌可塑性提供了一种新的策略.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 癌细胞表现出可塑性,使其能够通过类似干细胞或替代血统状态生存,往往导致治疗逃避.
- 细胞可塑性是驱动瘤进展和各种癌症治疗耐药性的关键机制.
研究的目的:
- 调查大麻素受体2 (CB2R) 激活在调节乳腺癌细胞身份和血统承诺中的作用.
- 探索CB2R激动剂在抑制瘤可塑性和增强治疗结果方面的潜力.
主要方法:
- 利用患者衍生和乳腺癌的小鼠器官模型.
- 用于短时间,低剂量暴露于植物性和合成CB2R激动剂.
- 分析了细胞自我更新,侵入性,瘤发起潜力和基因表达的变化.
- 在CB2R参与后研究了表观遗传修饰和染色质重塑.
主要成果:
- 在乳腺癌有机体中,CB2R激活诱导了不可逆转的基底细胞向光细胞的转变.
- 这种过渡与自我更新,侵入性和瘤发起能力的减少有关.
- 在通常促进脱差的条件下,诱导差异化的效应是稳定的.
- CB2R的参与启动了短暂的染色质重塑,导致表观遗传稳定差异化.
- 不同化的细胞对他莫西芬的反应增加,并且对抗性克隆的出现有限.
结论:
- CB2R激活代表了一种诱导乳腺癌细胞稳定血统承诺的新机制.
- 向CB2R提供了一种潜在的治疗策略,以限制癌细胞的可塑性并克服治疗耐药性.
- 通过CB2R引导癌细胞分化为改善乳腺癌治疗提供了新的机会.
更多相关视频
06:54Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
13.3K
08:48An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation
Published on: June 30, 2015
8.3K
相关概念视频
TGF - β Signaling Pathway
7.6K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.6K
Signal Transduction: Overview
9.4K
Cells respond to many types of information, often through receptor proteins positioned on the membrane. They respond to chemical signals, such as hormones, neurotransmitters, and other signaling molecules, initiating a series of molecular reactions to produce an appropriate response. This is called signal transduction. Cells also coordinate different responses elicited by the same signaling molecule via mediators, allowing molecular cross-talk.
Typically, signal transduction involves three...
Typically, signal transduction involves three...
9.4K
Receptor Downregulation in MVBs
2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.1K
Forced Transdifferentiation
2.0K
Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial...
Artificial...
2.0K
Intracellular Hormone Receptors
56.3K
Lipid-soluble hormones diffuse across the plasma and nuclear membrane of target cells to bind to their specific intracellular receptors. These receptors act as transcription factors that regulate gene expression and protein synthesis in the target cell
56.3K
Metastasis
5.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.7K